angiotensin ii has been researched along with Marfan Syndrome in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 2 (28.57) | 2.80 |
| Authors | Studies |
|---|---|
| Asano, K; Cantalupo, A; Ramirez, F; Sedes, L | 1 |
| Andersen, ND; Cavanaugh, NB; Dyle, MC; Gensicke, NM; Huang, T; Qian, L; Turek, JW | 1 |
| Dietz, H | 1 |
| Milewicz, DM; Prakash, SK; Ramirez, F | 1 |
| Aziz, H; Bedja, D; Chen, Y; Dietz, HC; Doyle, JJ; Habashi, JP; Holm, TM; Judge, DP; Modiri, AN; Schoenhoff, F | 1 |
| Aggarwal, A; Ahimastos, AA; D'Orsa, KM; Dart, AM; Formosa, MF; Kingwell, BA; Savarirayan, R; White, AJ | 1 |
| Aoka, Y; Aomi, S; Ishizuka, N; Kasanuki, H; Kawana, M; Koyanagi, H; Nagashima, H; Naruse, M; Ogawa, M; Sakomura, Y; Uto, K | 1 |
2 review(s) available for angiotensin ii and Marfan Syndrome
| Article | Year |
|---|---|
Pathophysiology and Therapeutics of Thoracic Aortic Aneurysm in Marfan Syndrome.
Topics: Angiotensin II; Animals; Aorta; Aortic Aneurysm, Thoracic; Aortic Dissection; Humans; Marfan Syndrome; Mice | 2022 |
Therapeutics Targeting Drivers of Thoracic Aortic Aneurysms and Acute Aortic Dissections: Insights from Predisposing Genes and Mouse Models.
Topics: Angiotensin II; Animals; Antihypertensive Agents; Aortic Aneurysm, Thoracic; Aortic Dissection; Disease Models, Animal; Genetic Predisposition to Disease; Humans; Losartan; Marfan Syndrome; Mechanoreceptors; Mice; Muscle, Smooth, Vascular; Signal Transduction; Transforming Growth Factor beta | 2017 |
2 trial(s) available for angiotensin ii and Marfan Syndrome
| Article | Year |
|---|---|
Effect of perindopril on large artery stiffness and aortic root diameter in patients with Marfan syndrome: a randomized controlled trial.
Topics: Adrenergic beta-Antagonists; Adult; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Aorta; Arteries; Blood Flow Velocity; Blood Pressure; Double-Blind Method; Echocardiography; Female; Humans; Male; Marfan Syndrome; Matrix Metalloproteinase 2; Matrix Metalloproteinase 3; Perindopril; Transforming Growth Factor beta; Ultrasonography, Doppler; Vasodilation | 2007 |
Angiotensin II type 2 receptor mediates vascular smooth muscle cell apoptosis in cystic medial degeneration associated with Marfan's syndrome.
Topics: Adult; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Aorta; Aortic Diseases; Apoptosis; Cell Count; Cells, Cultured; Culture Media, Serum-Free; Female; Humans; Imidazoles; Indoles; Male; Marfan Syndrome; Middle Aged; Muscle, Smooth, Vascular; Pyridines; ras Proteins; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Signal Transduction; Thiazepines; Tunica Media | 2001 |
3 other study(ies) available for angiotensin ii and Marfan Syndrome
| Article | Year |
|---|---|
Accelerated Marfan syndrome model recapitulates established signaling pathways.
Topics: Angiotensin II; Animals; Aorta; Aortic Aneurysm; Cardiomyopathies; Dilatation, Pathologic; Disease Models, Animal; Disease Progression; Extracellular Signal-Regulated MAP Kinases; Fibrillin-1; Genetic Predisposition to Disease; Heterozygote; Marfan Syndrome; Mice, Mutant Strains; Mutation; Myocardium; p38 Mitogen-Activated Protein Kinases; Phenotype; Phosphorylation; Signal Transduction; Smad2 Protein; Time Factors; Transforming Growth Factor beta | 2020 |
A healthy tension in translational research.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Awards and Prizes; Fibrillins; Humans; Loeys-Dietz Syndrome; Marfan Syndrome; Mice; Microfilament Proteins; Scleroderma, Systemic; Signal Transduction; Societies, Medical; Transforming Growth Factor beta; Translational Research, Biomedical; United States | 2014 |
Angiotensin II type 2 receptor signaling attenuates aortic aneurysm in mice through ERK antagonism.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta; Aortic Aneurysm; Aortic Rupture; Disease Models, Animal; Disease Progression; Enalapril; Losartan; MAP Kinase Signaling System; Marfan Syndrome; Mice; Mice, Knockout; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Receptor, Angiotensin, Type 2; Signal Transduction; Transforming Growth Factor beta | 2011 |